Birmingham, West Midlands -- (SBWIRE) -- 01/24/2014 -- Value Penny Stocks issues special report on Applied Materials, Inc. (NASDAQ:AMAT), LSI Corp (NASDAQ:LSI), Galena Biopharma Inc (NASDAQ:GALE), Dendreon Corporation (NASDAQ:DNDN).
Applied Materials, Inc. (NASDAQ:AMAT) ended its recent business day with the loss of -0.74% and closed at the price of $17.53 after opening at $17.51. The stock traded during its last trading session with the total volume of 8.23 million shares, as compared to its average volume of 8.97 million shares. Applied Materials, Inc. provides manufacturing equipment, services, and software to the semiconductor, flat panel display, solar photovoltaic (PV), and related industries worldwide. The company’s Silicon Systems Group segment develops, manufactures, and sells a range of manufacturing equipment used to fabricate semiconductor chips or integrated circuits.
Has AMAT Found The Bottom and Ready To Move Up? Find Out Here
LSI Corp (NASDAQ:LSI) remained among the day advancers and traded with volume of 7.59 million shares in the last session, as compared to average volume of 19.49 million shares. In comparison with 52 week range of $5.99 - $11.05, it faced lowest price of $11.00 during the last trading session whereas its day highest price was $11.03. The company’s total market capitalization is $6.01 billion, along with 544.94 million shares outstanding. LSI Corporation designs, develops, and markets storage and networking semiconductors worldwide. Its storage product portfolio includes hard disk, solid state, and tape drive solutions, which enable the reading and writing of digital data to and from the storage media, such as the hard disk drive platter or the flash memory cell.
Why Should Investors Buy LSI After The Recent Gain? Just Go Here and Find Out
Galena Biopharma Inc (NASDAQ:GALE) showed 7.52 million shares in volume during the last trading session, while the average trading volume remained 8.44 million shares. The stock kicked off its trading session at $5.85 and closed at $6.11 after mounting 0.83%. Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care. It is developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide.
For How Long GALE will Fight for Profitability? Read This Trend Analysis report
Dendreon Corporation (NASDAQ:DNDN) stock traded during its last trading session with the total traded volume of 7.45 million shares versus its average volume of 4.77 million shares. The company opened its trade at the price of $3.00 and its closing price was $2.88 after losing -4.32% for the day. Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. Its product portfolio includes active cellular immunotherapy and small molecule product candidates to treat a range of cancers.
Will DNDN Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)